Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Atheroma

glucose, (beta-d)-isomer has been researched along with Atheroma in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (35.71)24.3611
2020's9 (64.29)2.80

Authors

AuthorsStudies
Deng, W; Jia, Y; Li, H; Li, X; Liao, Y; Liu, K; Tan, Z; Tian, G; Yuan, Z; Zhang, H; Zhang, Y1
Chen, YC; Jandeleit-Dahm, K; Peter, K1
Katakami, N; Maeda, N; Mita, T; Sato, Y; Shimomura, I; Watada, H1
Cao, Z; Dong, X; Fu, J; Tu, Q; Wu, F; Xie, H; Xu, H1
Anto-Michel, N; Bode, C; Füner, L; Gissler, MC; Goldberg, IJ; Härdtner, C; Hilgendorf, I; Hoppe, N; Mullick, A; Pennig, J; Scherrer, P; Stachon, P; Willecke, F; Wolf, D; Zirlik, A1
Chen, L; Lei, X; Li, J; Li, WJ; Liu, X; Wang, K; Xing, SS; Yang, J; Yang, YT1
Fukuda, D; Ganbaatar, B; Hirata, KI; Kusunose, K; Sata, M; Shinohara, M; Soeki, T; Yagi, S; Yamada, H1
Ahmad, P; Alvi, SS; Iqbal, D; Khan, MS1
Li, X; Liu, L; Wang, S; Wu, M; Xing, Y; Yang, S; Zhao, R1
Chen, X; Hu, Y; Jing, Y; Li, H; Liang, J; Shi, Y; Wu, J; Xiong, Q; Yan, Z; Yuan, J; Zhang, Q; Zhou, L1
Aguilar-Ballester, M; Burks, DJ; González-Navarro, H; Herrero-Cervera, A; Martínez-Hervás, S; Real, JT; Taberner-Cortés, A; Vinué, Á1
Aihara, KI; Higashiguchi, F; Katagi, A; Kitagawa, T; Kurobe, H; Nakayama, T; Nishio, C; Sata, M; Shimabukuro, M; Sugasawa, N; Takumi, H1
Agrogiannis, G; Dimitriadis, GK; Kaltsas, G; Kassi, E; Kostakis, ID; Nasiri-Ansari, N; Nikiteas, N; Papavassiliou, AG; Patel, VH; Randeva, HS; Randeva, MS1
Cuong, TD; Jeon, BH; Lee, JH; Min, B; Ryoo, S; Shin, W; Woo, A1

Reviews

2 review(s) available for glucose, (beta-d)-isomer and Atheroma

ArticleYear
Insights into pharmacological mechanisms of polydatin in targeting risk factors-mediated atherosclerosis.
    Life sciences, 2020, Aug-01, Volume: 254

    Topics: Anticholesteremic Agents; Atherosclerosis; Cholesterol, LDL; Endothelial Cells; Fallopia japonica; Glucosides; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, LDL; Plaque, Atherosclerotic; Receptors, LDL; Risk Factors; Stilbenes

2020
Polydatin for treating atherosclerotic diseases: A functional and mechanistic overview.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 128

    Topics: Animals; Anti-Inflammatory Agents; Anticholesteremic Agents; Antioxidants; Arteries; Atherosclerosis; Cardiovascular Agents; Glucosides; Humans; Inflammation Mediators; Lipid Metabolism; Oxidative Stress; Plaque, Atherosclerotic; Signal Transduction; Stilbenes

2020

Trials

1 trial(s) available for glucose, (beta-d)-isomer and Atheroma

ArticleYear
Evaluation of the effect of tofogliflozin on the tissue characteristics of the carotid wall-a sub-analysis of the UTOPIA trial.
    Cardiovascular diabetology, 2022, 02-05, Volume: 21, Issue:1

    Topics: Adult; Aged; Benzhydryl Compounds; Carotid Arteries; Carotid Artery Diseases; Carotid Intima-Media Thickness; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Japan; Male; Middle Aged; Plaque, Atherosclerotic; Prospective Studies; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Treatment Outcome

2022

Other Studies

11 other study(ies) available for glucose, (beta-d)-isomer and Atheroma

ArticleYear
Panax notoginseng saponins inhibit Zymosan A induced atherosclerosis by suppressing integrin expression, FAK activation and NF-κB translocation.
    Journal of ethnopharmacology, 2011, Oct-31, Volume: 138, Issue:1

    Topics: Animals; Aorta; Atherosclerosis; Biological Transport; Disease Models, Animal; Foam Cells; Focal Adhesion Kinase 1; Integrins; Male; NF-kappa B; Panax notoginseng; Phosphorylation; Phytotherapy; Plant Extracts; Plaque, Atherosclerotic; Rats; Rats, Wistar; Saponins; Threonine; Zymosan

2011
Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor Dapagliflozin Stabilizes Diabetes-Induced Atherosclerotic Plaque Instability.
    Journal of the American Heart Association, 2022, 01-04, Volume: 11, Issue:1

    Topics: Animals; Benzhydryl Compounds; Constriction, Pathologic; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucose; Glucosides; Humans; Hypoglycemic Agents; Mice; Plaque, Atherosclerotic; Sodium; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin

2022
Empagliflozin inhibits macrophage inflammation through AMPK signaling pathway and plays an anti-atherosclerosis role.
    International journal of cardiology, 2022, 11-15, Volume: 367

    Topics: Adenosine; AMP-Activated Protein Kinases; Animals; Apolipoproteins E; Atherosclerosis; Benzhydryl Compounds; Blood Glucose; Glucosides; Inflammation; Lipoproteins, LDL; Macrophages; Mice; NF-kappa B; Plaque, Atherosclerotic; RNA; Signal Transduction; Sodium-Glucose Transporter 2 Inhibitors

2022
Glucose lowering by SGLT2-inhibitor empagliflozin accelerates atherosclerosis regression in hyperglycemic STZ-diabetic mice.
    Scientific reports, 2019, 11-29, Volume: 9, Issue:1

    Topics: Animals; Atherosclerosis; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Glucosides; Male; Mice; Mice, Inbred C57BL; Plaque, Atherosclerotic; Sodium-Glucose Transporter 2 Inhibitors

2019
Salidroside Decreases Atherosclerosis Plaque Formation via Inhibiting Endothelial Cell Pyroptosis.
    Inflammation, 2020, Volume: 43, Issue:2

    Topics: Animals; Atherosclerosis; Dose-Response Relationship, Drug; Glucosides; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice; Mice, Knockout; Phenols; Plaque, Atherosclerotic; Pyroptosis; Rhodiola

2020
Empagliflozin ameliorates endothelial dysfunction and suppresses atherogenesis in diabetic apolipoprotein E-deficient mice.
    European journal of pharmacology, 2020, May-15, Volume: 875

    Topics: Adipose Tissue; Animals; Aorta, Thoracic; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Eicosanoids; Endothelium, Vascular; Glucosides; Humans; Male; Mice; Mice, Knockout, ApoE; Plaque, Atherosclerotic; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin

2020
Polydatin alleviates high-fat diet induced atherosclerosis in apolipoprotein E-deficient mice by autophagic restoration.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2021, Volume: 81

    Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Autophagy; Diet, High-Fat; Glucosides; Male; Mice, Knockout, ApoE; Molecular Docking Simulation; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Plaque, Atherosclerotic; Proto-Oncogene Proteins c-akt; Stilbenes; TOR Serine-Threonine Kinases

2021
Dapagliflozin Does Not Modulate Atherosclerosis in Mice with Insulin Resistance.
    International journal of molecular sciences, 2020, Dec-03, Volume: 21, Issue:23

    Topics: Animals; Atherosclerosis; Benzhydryl Compounds; Blood Glucose; Computational Biology; Disease Models, Animal; Fasting; Glucose; Glucosides; Immunohistochemistry; Insulin Resistance; Macrophages; Mice; Mice, Knockout, ApoE; Plaque, Atherosclerotic; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors

2020
Inhibition of Atherosclerotic Plaque Development by Oral Administration of α-Glucosyl Hesperidin and Water-Dispersible Hesperetin in Apolipoprotein E Knockout Mice.
    Journal of the American College of Nutrition, 2019, Volume: 38, Issue:1

    Topics: Administration, Oral; Animals; Antioxidants; Apolipoproteins E; Cholesterol; Diet, High-Fat; Glucosides; Hesperidin; Male; Mice; Mice, Knockout; Plaque, Atherosclerotic

2019
Empagliflozin improves primary haemodynamic parameters and attenuates the development of atherosclerosis in high fat diet fed APOE knockout mice.
    Molecular and cellular endocrinology, 2019, 08-20, Volume: 494

    Topics: Administration, Oral; Animals; Atherosclerosis; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Diastole; Diet, High-Fat; Fasting; Glucosides; Heart Rate; Hemodynamics; Lipids; Metalloproteases; Mice, Inbred C57BL; Mice, Knockout, ApoE; Plaque, Atherosclerotic; RNA, Messenger

2019
Arginase inhibition by piceatannol-3'-O-β-D-glucopyranoside improves endothelial dysfunction via activation of endothelial nitric oxide synthase in ApoE-null mice fed a high-cholesterol diet.
    International journal of molecular medicine, 2013, Volume: 31, Issue:4

    Topics: Analysis of Variance; Animals; Aorta; Apolipoproteins E; Arginase; Diet, High-Fat; Enzyme Stability; Glucosides; Male; Mice; Mice, Knockout; Nitric Oxide Synthase Type III; Plaque, Atherosclerotic; Stilbenes; Vasoconstriction

2013